Hematopoietic Cell Transplantation For Epithelial Ovarian Cancer

The use of hematopoietic cell transplantation (HCT) has been investigated to treat patients with epithelial ovarian cancer. Hematopoietic stem cells are infused to restore bone marrow function after cytotoxic doses of chemotherapeutic agents with or without whole body radiotherapy. Stem cell transplantation to treat germ cell tumors of the ovary is considered separately in evidence review 02.003.003.